On 28 July, 2016, Bluestar Adisseo Company
(Adisseo) released its financial figures for H1 2016.
-
Total revenue: USD820.04 million (RMB5.44
billion), down 39% YoY
-
Net profit: USD166.27 million (RMB1.10
billion), largely up 109% YoY
-
New profit with extraordinary items
deducted: USD165.82 million (RMB1.10 billion), largely up 249% YoY
Source: Baidu
The significant profit growth was mainly attributed to:
1. Increase in methionine production capacity
In early 2016, the second phase of the company's methionine project (70,000
t/a) was put into operation, boosting the sales and profits. To date, Adisseo's
total production capacity of methionine in China has mounted to 140,000 t/a.
2. Surge in market price of vitamin A (VA)
As the fourth largest VA producer in the globe, Adisseo benefited a lot from
the large rise in the market price of VA at home and abroad in H1 2016.
According to CCM’s price monitoring, the market price of food grade VA (325,000
IU/g) in H1 2016 averaged USD62,288/t (RMB142,826/t), up 90% YoY.
3. Decrease in crude oil price
Thanks to the downward crude oil price, Adisseo lowered its production costs of
raw materials (oil derivatives). According to CCM's price monitoring, between
Jan. and June this year, the London Brent crude oil price averaged USD52.97/bbl,
down 14.36% YoY.
Adisseo's financial performance, H1 2015 & H1 2016
Source: Bluestar Adisseo Company
Monthly market price of food grade vitamin A
(325,000 IU/g) in China, Jan. 2015-July 2016
Source: CCM
According to Adisseo’s H1 2016 financial report,
the company's performance:
- By product
Performance products, including methionine, VA, ammonium sulfate and sodium
sulfate, are the largest contributor to the total revenue. Of this business:
-
Revenue: USD678.97 million (RMB4.50 billion),
82.81% of the company's total
Of the four aforementioned products, methionine takes a leading role. H1 2016
witnessed a fall in the methionine price. According to CCM's price monitoring,
the market price of methionine (imported fluid) averaged USD3,740/t
(RMB24,788/t), down 39% YoY. Affected by this, Adisseo's total revenue in H1
fell down. Yet, thanks to the high gross profit margin of performance product
business, the net profit showed significant growth.
- By region
Adisseo has its main markets in Europe, Africa and the Middle East, generating
a revenue of USD262.84 million (RMB17.42 billion) in H1, 30.05% of the
company's total. Notably, a revenue of USD110.90 million – RMB735 million (13.50%
of the total) came from the Chinese market which ranked fifth among all other
regions.
Adisseo's revenue by product,
H1 2016
Source: Bluestar Adisseo Company
Adisseo's revenue by region,
H1 2016
Source: Bluestar Adisseo
Company
Monthly market price of liquid methionine
in China, Jan. 2014-July 20166
Source: CCM
In 2015, Adisseo got listed on the Shanghai
Exchange Stock (A share). Currently, Adisseo has two main subsidiaries engaged
in production, Bluestar Adisseo (Nanjing) Co., Ltd. (BANC Nanjing) and Adisseo
France SAS (Adisseo France).
In particular, Adisseo France, the most
important one, is mainly in charge of the production of upstream products of
methionine as well as liquid and solid methionine (plant for liquid methionine
located in Burgos, Spain). In H1 2016, it generated a revenue of USD655.28
million (RMB4.34 billion) in H1 2016, 87.27% of Adisseo's total.
BANC Nanjing focuses on the production of
liquid methionine. This company and the Spanish plant complement each other in times
of production suspension for maintenance (given the stringent requirements for
production techniques and environmental protection, methionine plants should
have production facilities inspected from time to time).
At present, Adisseo targets at the R&D,
production and sale of feed additives. In 2015, the company developed and
launched protected methionine (with the functions of raising protein levels in
milk and lactating ration of ruminants) for ruminants such as dairy cows. In
Aug. 2016, Adisseo announced that its industry category has been converted from
chemical manufacturing (code: C26) to medical manufacturing (code: C27),
indicating a clearer market positioning.
Adisseo's net profit by subsidiary, H1 2016
Note: Adisseo France stands for Adisseo
France SAS;
BANC
Nanjing stands for Bluestar Adisseo (Nanjing) Co., Ltd.;
Figures
are based on financial information before elimination of the entities.
Source: Bluestar Adisseo Company
This article comes from Amino Acids China E-News 1608, CCM
About CCM:
CCM is the leading market intelligence provider for China’s
agriculture, chemicals, food & ingredients and life science markets. Founded in 2001, CCM offers a
range of data and content solutions, from price and trade data to industry
newsletters and customized market research reports. Our clients include Monsanto,
DuPont, Shell, Bayer, and Syngenta. CCM is a brand of Kcomber Inc.
For more information about CCM, please visit www.cnchemicals.com or get in touch with us
directly by emailing econtact@cnchemicals.com or calling
+86-20-37616606.
Tag: methionine Amino Acids